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Technology has quickly become an integral part of society over the last
century. Most of what is now considered common technology has not always been
so easily available to the general public. With every improvement in the world of
technology that seems small, huge advancements can arise. Many of these trivial
improvements have monumentally impacted society as a whole. The evolution of
technology as a whole has laid the groundwork for countless industrial
advancements that have improved the inner and outer workings of today’s world.
More specifically, these advances have developed and transformed the everexpanding realm of healthcare. While the implementation of technology has
improved many aspects of healthcare, it is also possible for the application of these
technologies to have negative implications as well. As society strives to continuously
improve, the medical field stops at nothing to provide the highest quality of
healthcare possible. Finding and appreciating the balance of when technology may
bring about more harm than good will dramatically change and improve healthcare
as a whole. While healthcare in its entirety encompasses too many different
disciplines to adequately and thoroughly investigate the effect that technology has
had, this paper will investigate and consider just a few of these countless
technological advances within the medical field. These advances will include the
completion of the Human Genome Project and the scientific healthcare advances
that have accompanied it.
The Human Genome Project is an extensive example of technology use in the
medical field. Without technology and the ambitions to constantly improve upon it,
this project would have never been successful. Overall, the Human Genome Project
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was designed to decipher and interpret the entire sequence of the human genome in
order to use it as a reference for future discoveries. After decoding this reference
human genome sequence, this project led to the development of innovative
technologies and tools to be used in countless ways. Not only has it helped in the
realm of healthcare, but beyond medicine as well. In addition to changing the world
of medicine, the Human Genome Project has revolutionized the disciplines of
microbiology, virology, infectious disease and plant biology. (Hood) However, for
the purpose of this paper, the investigation of the Human Genome Project will stay
within the boundaries of healthcare and medicine.
Since the decoding of the reference human genome, individual genome
sequences are starting to play a more important role in medicine and healthcare. In
today’s society, and more so in the future, patients will have the ability to customize
their own healthcare based on their individual genome. Doctors will be able to
recommend more preventative medicine if they interpret a genome and see the
potential for the development of minor or more serious diseases. In addition to
individualizing preventative medicine, doctors can individualize therapeutic
programs to prevent or treat current or potential conditions suggested by their
individual genome sequence. (Hood) Currently, the process to sequence the human
genome is not being used routinely in everyday medicine, however, the sequencing
of the human genome only costs $100 or less and can take 15 minutes or less. Once
the process of sequencing the human genome has become more widely accepted, it
will make diagnosis and treatment easier and more individualized, improving the
healthcare provided to each patient.
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As genetic testing is becoming more and more accessible, it is also becoming
easier to personalize healthcare. Even before genetic testing was possible, diagnosis
included the consideration of environmental influences and also the familial history
of disease. (Blix) A family history can be an important tool that doctors use to
diagnose an individual. If a patient is having certain symptoms and the doctor
knows that the symptoms align with a disease that runs in their family, that
information can help to confirm a diagnosis. However, with more advanced
technologies, doctors will be able to use the patients genome to help diagnose the
individual instead of relying on the familial history given by the patient. Often times,
the history given by the patient has many gaps and at times can contain incorrect
information. Now that research has revealed more about genetics and genomics,
these discoveries have helped in the fields of medicine and pharmacology, affecting
risk assessment, diagnosis, prognosis, and treatment. (Blix) Especially in cancer
situations, genetic assessment can be used to find the potential for familial risk
based on an individuals’ genome. In the area of diagnosis, genomics is also becoming
more popular in order to differentiate different subtypes of cancers. This is an
important step forward when it comes to the diagnosis and treatment of each
individual cancer. This has even lead to the beginning of the Cancer Genome Atlas
project. The ability to genome a cancer cell has also become important when it
comes to determining the severity of disease the prognosis. (Blix) Understanding
the progression of the disease and prognosis for the patient is important
information for the patient when it comes to making important decisions about
their well-being and future.
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Researchers are continuing to use the information provided by the Human
Genome Project to improve healthcare. In the field of pharmacogenomics,
researchers have found more than 70 genes that have specific variants that can
cause ineffective drug metabolism in humans. (Hood) Pharmacogenetics is a field of
research that helps to understand how an individual’s genetics can display their
inter-individual variability in response to different drugs. Pharmacogeneticists
study individual genomes to identify inherited genetic differences in drug metabolic
pathways, which can influence an individual’s response to various medications. In
medical terms, this can mean metabolizing a drug too quickly and therefore
decreasing the length of benefit, or too slowly causing an increase concern for
toxicity. Altered drug metabolic pathways can also affect the drugs therapeutic
effect and the adverse effects of the drug. The term pharmacogenetics is used to
describe a single variation, or a polymorphism, in the genome and how it can affect
drug response. (Birdwell) The majority of drugs display this type of inter-individual
variation in their effectiveness. One of the most important applications of
pharmacogenetics is simply to avoid some of the more serious and life threatening
adverse reactions a drug can induce.
Approving new drugs involves many different steps and the success of the
drug is based on its effectiveness. Generally, their efficacy is based on the average
response of the group used in the study. However, this average implies there are still
individuals with little to no response and other individuals with too powerful of a
response. These individuals with little to no response or an above average response
are such a small percentage of the total number of individuals in the group that their
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responses don’t affect the overall efficacy of the drug. When treating more complex
diseases, these patients often go through ‘trial-and-error’ periods until a sufficiently
successful therapy has been found. (Liggett) This trial-and-error period includes
changing the dosage and frequency of drug administration, or changing the drug
itself to a different drug with the same benefit. This can often be a frustrating and
time consuming strategy to find the proper treatment. It is also important to
consider that during this trial period, the patient may not be experiencing any relief
because the dosage, frequency, or drug may not be administered optimally. Using
the information that the genome provides, patients with an altered pattern of drug
metabolism can be given different doses or frequencies without the hassle of a long
trial-and-error period. Drugs can also be chemically modified in order to
accommodate this altered pattern of drug metabolism.
In addition to identifying individuals with unique drug metabolisms, genetic
testing can help to determine whether an individual is likely to experience side
effects when taking a certain drug. Each individual will react to a drug differently.
Oftentimes it does not cause harmful results, but there are times where the reaction
to the drug is worse than the problem the drug was originally treating. The ability to
foresee the occurrence of any side effects can help doctors suggest strategies to
reduce or eliminate them and improve the health and livelihood of the individual.
This application of pharmacogenetics allows doctors to choose the best drug out of
all the available options, choose the correct dose and frequency right away, and save
time and money by not having the trial-and-error period. These are benefits that can
be very important when it comes to the overall wellbeing and care of the patient.
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The Human Genome Project has also identified hundreds of ‘actionable gene
variants.’ (Hood) These actionable gene variants are variations of various genes that
have the potential to cause disease. Sequencing an individual’s genome and
identifying these specific actionable gene variants can indicate the need for medical
intervention in order to avoid experiencing the effects of the disease. The
sequencing of individual genomes can also help to identify various mutations that
cause cancer. Once a cancer causing mutation occurs, it is important to start
treatment as soon as possible after it has been identified. Once the mutation causing
the cancer has been identified, doctors can use treatments and medications that are
already on the market in order to try to treat and counteract the mutation. (Hood)
This can include using a specific drug that is well-known to treat a certain mutation.
It can also include formulating a new and personalized cocktail of several drugs that
are already on the market to try to combat the mutation. With a disease like cancer,
many treatments need to be highly individualized because different mutations
require different treatments. Given the nature of mutations and cancer, using drugs
that are already on the market is much more timely and can be much more affective.
The development and approval of new drugs to treat new mutations is very costly
and can take several years. It is costly for both the pharmaceutical company and the
patient because new drugs under patents are considerably more expensive because
the company must make back the money they lost during the development of the
drug. Even so, with these important considerations aside, when a new drug is finally
approved, it is possible that the mutation the drug was developed to counteract has
changed and mutated again and the drug will not be as affective as expected. With
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the sequencing of cancer genes, drugs that are already on the market can be tailored
and used in individuals to fight certain types of cancer mutations.
The Human Genome Project was the first example of a ‘large-scale data
acquisition.’ It was an extensive group project. The project itself required the
cooperation of engineers, computer scientists, mathematicians, and biologists in
order to create data sharing and specific software to interpret the information and
to make the results of the project obtainable by everyone. The technological
advancements made to accomplish the Human Genome Project started to
revolutionize the realm of science and more specifically medicine. Not only did the
Human Genome Project suggest new ways to prevent and treat disease in the future,
it also inspired future large-scale data acquisitions such as: the International
HapMap Project, 1000 Genomes, the Cancer Genome Atlas, the Human Brain Project
and the Human Proteome Project. (Hood) Each of these projects will continue to
influence the medical field and allow for dynamic and exceptional healthcare.
From the creation of the Human Genome Project, many companies have
taken on this idea to improve their own research. A company called 23andMe is a
well-known company striving to help people access, understand and benefit from
the human genome. The idea behind this company is so individuals can order a DNA
testing kit, follow the instructions and send it back to the company. The company
will then interpret the DNA from the kit and send the results back to the individual.
A unique characteristic of this company is if the individual chooses to participate,
they can also give the company permission to use their DNA in research to help
learn more about various diseases. The individual simply checks a box on the
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pamphlet from the testing kit and once the company has interpreted the DNA, they
send the results to the individual and then use the results for their own research.
Participation in this research could potentially help with disease prevention,
improved drug therapies, disease treatments and genetic paths to cures. It can also
provide information about how various diseases are passed down through
generations. However, not only can these DNA tests help to discover treatments and
cures for the future, it can also be used to study ancestry, connecting people all
around the world. This company is one of many that are trying to make genetic
testing more common and effortless in order to help individuals learn more about
themselves and their own healthcare.
While the Human Genome Project has revolutionized modern science and
modern medicine, it has also introduced a new ethical consideration that wasn’t
possible until now. Having the ability to sequence the genome could provide the
doctor with life-changing information for the patient. A general example of this
would include finding possible causes of death of an individual based on their
genome. One significant example would be in the case Alzheimer’s Disease. Although
the cause of late-onset Alzheimer’s Disease is unknown and is suggested to be
related to both genetics and environmental factors, the inheritance pattern of earlyonset Alzheimer’s Disease is autosomal dominant. This means that an individual
only needs one copy of the gene, instead of two, in order to develop Alzheimer’s
disease. Since early-onset Alzheimer’s Disease typically presents itself in the ages of
30s, 40s, and 50s, an individual with the dominant gene has most likely already
reproduced and passed their genes onto their offspring without knowing. The
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chance that any one of their offspring will inherit the gene for early-onset
Alzheimer’s Disease is 50%. With the ability to sequence the human genome,
individuals whose parents have developed early-onset Alzheimer’s Disease can have
their genome sequenced to see if their genome also contains an inherited autosomal
dominant gene linked to Alzheimer’s Disease. This brings many ethical
considerations to light. Although there are several more ideas to consider, the two
main considerations involve the decisions the individuals makes about their future.
Before knowing whether or not a person has the gene for early-onset Alzheimer’s
Disease they may have dreams to get married and start a family. However, if an
individual carries the gene, they may choose not to start a family in order to prevent
passing the gene on to the next generation. However, to counteract this perspective,
the individual may not live the life they dreamed and may live with fear and anxiety
of what will happen to them in the future. This fear and anxiety may also lead to
other illnesses and disease states, diminishing their overall health. While the Human
Genome Project has helped to improve healthcare tremendously, it is important to
gain an appreciation for the technology available, but also to understand how to
create a balance when it comes to technology use in the world of healthcare. Just
because the technology allows individuals to gather this information about
themselves, doesn’t mean it should be done.
Downs Syndrome is another example of how technology has brought about
various ethical dilemmas. Downs Syndrome is the trisomy of chromosome 21. As
humans, we function optimally with two of each chromosome. Any type of variation
from this norm causes abnormalities. Although the individual will live with
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abnormalities, there are three types of chromosomes that when in trisomy the
human can survive. Chromosomes 13, 18, and 21 are the only trisomies that make it
to birth, and even then many of them do not make it to birth. All other chromosomal
trisomies will naturally abort, often before a pregnancy is diagnosed. Before birth,
during gestation, a mother can choose to find out whether or not the child has
Downs Syndrome. Based on the outcome of these tests the mother can choose to
abort the pregnancy and there are times when this option is even recommended by
the physician. Although the child can still live a happy life with Downs Syndrome,
the mother has the ability to end the pregnancy if she does not want to have a child
with Downs Syndrome. This ethical dilemma illustrates some of the difficult
decisions that come along with the use of technology in healthcare.
In addition to the examples of Alzheimer’s Disease and Downs Syndrome,
genetic testing and genetic counseling have been shown to be beneficial in the case
of cancer. As specified earlier, genetic testing of the disease itself can help doctors
choose the proper treatment in order to offer the most promising prognosis for the
patient. However, in the case of family history, an individual can find out if they
carry the genes that could become cancer. If an individual carries the gene that
doesn’t mean that they will get cancer, but it drastically increases their likelihood of
developing cancer. This use of genetic testing is often used as a preventative
measure. In the case of breast cancer, if an individual is likely to develop the disease,
there are man preventative options. They can choose to have a double mastectomy
before the disease has progressed at all, preventing the cancer from starting in the
first place. If the organ that the cancer targets is removed before the cancer
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develops then the cancer can no longer develop in that organ. This situation is
different from that of early onset Alzheimer’s Disease because Alzheimer’s Disease
cannot be prevented as of now. Choosing to have genetic testing done in order to
undergo preventative surgery or treatment for a disease like cancer does not bring
about the same ethical dilemmas and decisions that genetic testing for Alzheimer’s
Disease suggests.
The Human Genome Project was just the beginning of many genome projects
to come, all influencing the medical field in different ways. Another specific project
that is still in the workings is the Human Microbiome Project. The human
microbiome includes the microbial on the surface of and within the human body.
The idea of this project came after the Human Genome Project because there was a
growing interest in sequencing the genomes of the microbial life in and on the
human body. (Gevers) Researchers understood that the microbiome was necessary
and beneficial to human health but they had no understanding of the specifics of the
microbial matter. After significant research, it was discovered that the
gastrointestinal tract harbors the most prolific and one of the most diverse
microbial communities of the entire human body. (Manichanh) The human body is
comprised of two genomes, one is inherited through our genetic lineage, and the
other is acquired. (D’Argenio) Unlike the typically stable inherited genome, the
acquired genome is dynamic and can be influenced by a number of factors.
(D’Argenio) This acquired genome includes the genetic diversity of microorganisms
living on the surface of and within the body itself. Together, with hundreds more,
these microorganisms contribute to the health of every human being. Due to the
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lymphoid tissues present within the mucosa and the magnitude and complexity of
the microorganisms within it, the gut microbiome is important for maintain the
homeostasis of individuals. (Manichanh)
There are various events that can influence the microorganisms within the
human gut. With the help of the Human Microbiome Project many discoveries have
been found that can be used to help individuals make better decisions regarding
their health and the health of those around them. Researchers have discovered that
the development of the gut microbiota begins during the birthing process. Before
this moment, an infant is sterile. (D’Argenio) During vaginal delivery, the infant
comes into contact with the mothers’ vaginal and intestinal flora. This is an
important source for microorganisms that will begin to colonize in the gut of the
infant. This source of microorganisms is so important because it contains many of
the types of microorganisms within the gastrointestinal tract of the mother. The
predominant species acquired from a vaginal birth include lactobacillus, prevotella,
and other bifidobacterium. (Torrazza) Unlike during vaginal delivery, the infant is
not exposed to the same flora during a cesarean delivery. During a cesarean
delivery, direct contact of the mouth of the infant with the vaginal and intestinal
flora is absent. (Torrazza) The infants delivered by cesarean are exposed to nonmaternally derived and less diverse flora dominated by staphylococcus with delayed
intestinal colonization by lactobacillus, bifidobacterium and bacteroides. (Torrazza)
Depending on if a child is delivered vaginally or via cesarean birth, the individual
may have a drastically different microbial composition and acquired genome and
therefore the metabolism, nutrition, immunological functions and pathogen defense
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can be different. This can have lasting effects on the individual as it develops. There
have been links found in infants delivered by cesarean showing that they display
diseases such as Asthma, type 1 diabetes, allergies, celiac disease, irritable bowel
disease and obesity more often than infants delivered vaginally. (Torrazza)
In addition to the mode of delivery and its influence on the development of
the microbiome, individuals on antibiotics have an altered gut microbiota. This is
commonly found in the medical field. Antibiotics are some of the most commonly
prescribed drugs in the United States and each antibiotic comes with its own
adverse side effects. Often times, antibiotics can lead to stomach and intestinal
upset. This is due to the change in microbial diversity within the gut. Antibiotics are
unable to decipher between good and bad bacteria. Antibiotics are used to get rid of
bacteria within the body that are causing illness, but in doing so, antibiotics can also
destroy some of the good bacteria within the gut, leading to a disequilibrium and
unfortunate adverse reactions. These adverse reactions can include stomach upset,
loose or watery bowel, and diarrhea. Due to these adverse reactions, there have
been suggested ways to reestablish the microbial diversity within the gut in order to
avoid some of these adverse side effects before they begin. The use of probiotics is a
relatively new topic in research. Since antibiotics alter the intestinal flora, it can lead
to symptoms such as large watery bowel movements and cramping abdominal pain.
One small study concentrated on antibiotic-associated diarrhea focused on the use
of Lactobacillus reuteri, which was found to decrease the frequency of diarrhea in
patients receiving antibiotics within hospital setting. (Balakrishnan)
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Another disease that is gaining attention in the medical field is C. difficile.
This is one of the most commonly seen nosocomial infections in both the hospital
and nursing home settings. (Balakrishnan) C. difficile is an microbe that is always
present in the gut microbiota, however, not in concentrations that cause harm. The
use of antibiotics can alter the gut microbiota allowing the C. difficile to germinate
and grow and increase in concentration within the gut. This common and growing
problem has helped in the development of more ways to reestablish an altered gut
microbiota. In addition to probiotics, another way to reestablish the microbial
equilibrium is through fecal microbiota transplants. Fecal microbiota
transplantation is the process of delivering a saline stool suspension from a healthy,
preapproved donor into the patient’s upper gastrointestinal tract. (Lofland) It works
to restore the microbial homeostasis within the intestinal environment in order to
relieve the diarrhea and colitis that is associated with an overgrowth of C. difficile by
increasing the population of good bacteria. (Lofland) With the help of further
research, more information about the varying genomes in the gut will help to learn
more about probiotics, fecal microbiota transplantation and other treatments will
be revealed and integrated into the medical care of individuals suffering from an
altered gut microbiota.
Once the human genome project was completed, the technology that was
used has continued to help the medical field in many different ways. With the
human microbiome project, there is still much more research to do, but so much has
already been found and has helped many individuals. With the knowledge of how
the birthing process can change the microbial diversity of an individual, healthcare
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workers can help individuals make more educated decisions about their lives and
the lives of their children. Also, the knowledge of how to re-establish a low microbial
diversity gut has been very beneficial in the medical field and improving the lives of
many individuals.
Overall, technology has had a profound impact on the healthcare community.
Although this paper only covers a small percentage of the impact, it is easy to say
that technology has revolutionized modern medicine and diagnostics. While there
are so many obvious aspects of technology that have been beneficial and extremely
significant in improving the healthcare that is provided, many of the unfavorable
effects have been overlooked. These unfavorable effects include the ethical
situations that come up when technology allows individuals to gain access to
specific personal information they would not have been able to obtain had
technology not intervened. Ultimately, this purpose of this paper is to provoke
thoughts and reflection on how technology has permeated the healthcare system. As
each individual has the ability to make their own decisions in regards to their health,
it is important to learn to appreciate the role that technology should have in such a
personal aspect of life but also to set boundaries where technology should not
penetrate.
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